DK165688C - 5,7,8-trisubstituerede 2,3,4,5-tetrahydro-1h-3-benzazepiner, farmaceutiske praeparater indeholdende forbindelserne og anvendelse af forbindelserne til fremstilling af farmaceutiske praeparater til behandling af psykoser - Google Patents
5,7,8-trisubstituerede 2,3,4,5-tetrahydro-1h-3-benzazepiner, farmaceutiske praeparater indeholdende forbindelserne og anvendelse af forbindelserne til fremstilling af farmaceutiske praeparater til behandling af psykoserInfo
- Publication number
- DK165688C DK165688C DK652688A DK652688A DK165688C DK 165688 C DK165688 C DK 165688C DK 652688 A DK652688 A DK 652688A DK 652688 A DK652688 A DK 652688A DK 165688 C DK165688 C DK 165688C
- Authority
- DK
- Denmark
- Prior art keywords
- compounds
- benzazepines
- tetrahydro
- preparations
- alkyl
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 238000002360 preparation method Methods 0.000 title abstract 2
- 239000000825 pharmaceutical preparation Substances 0.000 title 2
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 125000004183 alkoxy alkyl group Chemical group 0.000 abstract 3
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 3
- 125000000392 cycloalkenyl group Chemical group 0.000 abstract 2
- 125000001188 haloalkyl group Chemical group 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- -1 1-substituted-2,3,4,5-tetrahydro-1H-3-benzazepines Chemical class 0.000 abstract 1
- 208000028017 Psychotic disease Diseases 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000000168 pyrrolyl group Chemical group 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/32—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems containing carbocyclic rings other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Neurology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3213587A | 1987-03-27 | 1987-03-27 | |
| US3213587 | 1987-03-27 | ||
| PCT/US1988/000899 WO1988007526A1 (fr) | 1987-03-27 | 1988-03-24 | Benzazepines substituees, preparation de ces composes et compositions pharmaceutiques contenant ces composes |
| US8800899 | 1988-03-24 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| DK652688D0 DK652688D0 (da) | 1988-11-23 |
| DK652688A DK652688A (da) | 1988-11-23 |
| DK165688B DK165688B (da) | 1993-01-04 |
| DK165688C true DK165688C (da) | 1993-05-24 |
Family
ID=21863286
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK652688A DK165688C (da) | 1987-03-27 | 1988-11-23 | 5,7,8-trisubstituerede 2,3,4,5-tetrahydro-1h-3-benzazepiner, farmaceutiske praeparater indeholdende forbindelserne og anvendelse af forbindelserne til fremstilling af farmaceutiske praeparater til behandling af psykoser |
Country Status (18)
| Country | Link |
|---|---|
| EP (2) | EP0357641A1 (fr) |
| JP (1) | JPH0662574B2 (fr) |
| KR (1) | KR930011489B1 (fr) |
| AT (1) | ATE112766T1 (fr) |
| AU (1) | AU619744B2 (fr) |
| CA (1) | CA1321195C (fr) |
| DE (1) | DE3851769T2 (fr) |
| DK (1) | DK165688C (fr) |
| FI (1) | FI894566A0 (fr) |
| HU (1) | HU205744B (fr) |
| IL (1) | IL85855A (fr) |
| MY (1) | MY103357A (fr) |
| NO (1) | NO174507B (fr) |
| NZ (1) | NZ224038A (fr) |
| PH (1) | PH27337A (fr) |
| PT (1) | PT87068B (fr) |
| WO (1) | WO1988007526A1 (fr) |
| ZA (1) | ZA882080B (fr) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK107688D0 (da) * | 1988-03-01 | 1988-03-01 | Novo Industri As | Carbaminsyreestere af substituerede 7-hydroxy-2,3,4,5-tetrahydro-1h-3-benzazepiner |
| DK67489D0 (da) * | 1989-02-14 | 1989-02-14 | Novo Industri As | Nye benzazepinderivater |
| US5068326A (en) * | 1989-04-03 | 1991-11-26 | Kung Hank F | Dopamine receptor ligands and imaging agents |
| AU8201591A (en) * | 1990-06-15 | 1992-01-07 | Schering Corporation | 8-lower alkyl-5-cycloalkyl or 5-cycloalkenyl substitued benzazepines and pharmaceutical compositions containing them |
| AU8536591A (en) * | 1990-09-25 | 1992-04-15 | Schering Corporation | Peri-condensed benzazepines |
| US5241065A (en) * | 1992-02-25 | 1993-08-31 | Schering Corporation | 2,3,4,5-tetrahydro-1h-3-benzazepines having anti-psychotic activity |
| US7001898B2 (en) * | 2000-07-05 | 2006-02-21 | Ortho-Mcneil Pharmaceutical, Inc. | Nonpeptide substituted spirobenzoazepines as vasopressin antagonists |
| US6953787B2 (en) * | 2002-04-12 | 2005-10-11 | Arena Pharmaceuticals, Inc. | 5HT2C receptor modulators |
| KR100897642B1 (ko) * | 2002-12-20 | 2009-05-14 | 글락소 그룹 리미티드 | 신경 장애 치료용 벤즈아제핀 유도체 |
| WO2005035504A2 (fr) | 2003-05-22 | 2005-04-21 | Schering Corporation | Antagonistes selectifs des recepteurs d1/d5 utilises dans le traitement de l'obesite et des troubles du systeme nerveux central |
| CN1805938B (zh) | 2003-06-17 | 2010-06-16 | 艾尼纳制药公司 | 用于治疗5ht2c受体相关疾病的苯并氮杂卓衍生物 |
| AU2012200805B2 (en) * | 2003-06-17 | 2015-01-22 | Arena Pharmaceuticals, Inc. | Benzazepine derivatives useful for the treatment of 5HT2C receptor associated diseases |
| PL2332921T3 (pl) * | 2003-06-17 | 2016-08-31 | Arena Pharm Inc | Chlorowodorek 8-chloro-1-metylo-2,3,4,5-tetrahydro-1H-3-benzazepiny |
| WO2005042490A1 (fr) * | 2003-10-22 | 2005-05-12 | Arena Pharmaceuticals, Inc. | Derives de benzazepine et methodes de prophylaxie ou de traitement de maladies associees au recepteur 5-ht2c |
| US20080009478A1 (en) * | 2003-10-22 | 2008-01-10 | Arena Pharmaceuticals, Inc. | Benzazepine Derivatives and Methods of Prophylaxis or Treatment of 5Ht2c Receptor Associated Diseases |
| NZ555981A (en) | 2004-12-21 | 2011-01-28 | Arena Pharm Inc | Crystalline forms of (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride |
| BRPI0515862A2 (pt) | 2004-12-23 | 2011-10-11 | Arena Pharm Inc | uso de fentermina e agonista seletivo do receptor de 5ht-2c na preparação de composições, composições moduladoras do receptor de 5ht-2c e forma de dosagem unitária compreendendo as mesmas |
| EP2001852A2 (fr) | 2006-04-03 | 2008-12-17 | Arena Pharmaceuticals, Inc. | Procédés de préparation de 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine et produits intermédiaires associés |
| CN101547892B (zh) | 2006-12-05 | 2014-08-20 | 艾尼纳制药公司 | 制备(r)-8-氯-1-甲基-2,3,4,5-四氢-1h-3-苯并氮杂卓的方法和其中间体 |
| EP2288585A1 (fr) | 2008-03-04 | 2011-03-02 | Arena Pharmaceuticals, Inc. | Procédés de préparation d'intermédiaires se rapportant à l'agoniste 5-ht2c (r)-8-chloro-1-méthyl-2,3,4,5-tétrahydro-1h-3-benzazepine |
| US8952197B2 (en) | 2009-06-18 | 2015-02-10 | Arena Pharmaceuticals, Inc. | Processes for the preparation of 5-HT2C receptor agonists |
| US9045431B2 (en) | 2010-06-02 | 2015-06-02 | Arena Pharmaceuticals, Inc. | Processes for the preparation of 5-HT2C receptor agonists |
| AU2011296015B2 (en) | 2010-09-01 | 2015-11-12 | Arena Pharmaceuticals, Inc. | Administration of lorcaserin to individuals with renal impairment |
| JP6272695B2 (ja) | 2010-09-01 | 2018-01-31 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 体重管理のために有用な５−ｈｔ２ｃアゴニストの改変放出剤形 |
| JP2013536859A (ja) | 2010-09-01 | 2013-09-26 | アリーナ ファーマシューティカルズ， インコーポレイテッド | ５−ｈｔ２ｃアゴニストの非吸湿性塩 |
| KR20130138770A (ko) | 2010-09-01 | 2013-12-19 | 아레나 파마슈티칼스, 인크. | 광학적으로 활성 산을 갖는 로르카세린의 염 |
| JP2015534563A (ja) | 2012-10-09 | 2015-12-03 | アリーナ ファーマシューティカルズ， インコーポレイテッド | 体重管理の方法 |
| HU230826B1 (hu) | 2014-11-19 | 2018-07-30 | Richter Gedeon Nyrt. | Eljárás benzazepin származékok előállítására |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA974989A (en) * | 1968-03-11 | 1975-09-23 | Wallace And Tiernan Inc. | Process for preparing 1,2,4,5-tetrahydro-3h,3-benzazepines and products obtained thereby |
| DE1934150A1 (de) * | 1968-07-10 | 1970-01-15 | Pennwalt Corp | Neue 1-Alkanoyloxy-1,2,4,5-tetrahydro-3H,3-benzazepine |
| US4988690A (en) * | 1982-06-14 | 1991-01-29 | Hoechst-Roussel Pharmaceuticals Inc. | 1-aryloxy-2,3,4,5-tetrahydro-3-benzazepines and anti-depressant use thereof |
| DK180485D0 (da) * | 1985-04-22 | 1985-04-23 | Novo Industri As | Nitrogenholdige forbindelser |
| US4707483A (en) * | 1985-12-20 | 1987-11-17 | Smithkline Beckman Corporation | 1-phenyl-3-benzazepines and their use for treating gastrointestinal motility disorders |
| GB8807922D0 (en) * | 1988-04-05 | 1988-05-05 | Fujisawa Pharmaceutical Co | Isoquinoline compound & process for preparation thereof |
-
1988
- 1988-03-23 ZA ZA882080A patent/ZA882080B/xx unknown
- 1988-03-23 PH PH36675A patent/PH27337A/en unknown
- 1988-03-24 JP JP63503399A patent/JPH0662574B2/ja not_active Expired - Lifetime
- 1988-03-24 HU HU882812A patent/HU205744B/hu not_active IP Right Cessation
- 1988-03-24 IL IL85855A patent/IL85855A/xx not_active IP Right Cessation
- 1988-03-24 PT PT87068A patent/PT87068B/pt not_active IP Right Cessation
- 1988-03-24 EP EP88903596A patent/EP0357641A1/fr active Pending
- 1988-03-24 EP EP88104758A patent/EP0285919B1/fr not_active Expired - Lifetime
- 1988-03-24 AU AU15964/88A patent/AU619744B2/en not_active Ceased
- 1988-03-24 KR KR1019880701534A patent/KR930011489B1/ko not_active Expired - Fee Related
- 1988-03-24 WO PCT/US1988/000899 patent/WO1988007526A1/fr not_active Ceased
- 1988-03-24 MY MYPI88000305A patent/MY103357A/en unknown
- 1988-03-24 DE DE3851769T patent/DE3851769T2/de not_active Expired - Fee Related
- 1988-03-24 CA CA000562352A patent/CA1321195C/fr not_active Expired - Fee Related
- 1988-03-24 AT AT88104758T patent/ATE112766T1/de not_active IP Right Cessation
- 1988-03-25 NZ NZ224038A patent/NZ224038A/xx unknown
- 1988-11-15 NO NO885096A patent/NO174507B/no unknown
- 1988-11-23 DK DK652688A patent/DK165688C/da active
-
1989
- 1989-09-27 FI FI894566A patent/FI894566A0/fi not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| FI894566A7 (fi) | 1989-09-27 |
| NZ224038A (en) | 1990-10-26 |
| PT87068A (pt) | 1988-04-01 |
| NO174507C (fr) | 1994-05-18 |
| DK652688D0 (da) | 1988-11-23 |
| DK652688A (da) | 1988-11-23 |
| KR930011489B1 (ko) | 1993-12-08 |
| NO174507B (no) | 1994-02-07 |
| EP0357641A1 (fr) | 1990-03-14 |
| NO885096D0 (no) | 1988-11-15 |
| EP0285919B1 (fr) | 1994-10-12 |
| ZA882080B (en) | 1989-04-26 |
| JPH0662574B2 (ja) | 1994-08-17 |
| HU205744B (en) | 1992-06-29 |
| HUT53882A (en) | 1990-12-28 |
| FI894566A0 (fi) | 1989-09-27 |
| ATE112766T1 (de) | 1994-10-15 |
| CA1321195C (fr) | 1993-08-10 |
| KR890700577A (ko) | 1989-04-25 |
| EP0285919A1 (fr) | 1988-10-12 |
| IL85855A0 (en) | 1988-09-30 |
| PH27337A (en) | 1993-06-08 |
| IL85855A (en) | 1993-02-21 |
| DE3851769D1 (de) | 1994-11-17 |
| JPH02502723A (ja) | 1990-08-30 |
| MY103357A (en) | 1993-06-30 |
| NO885096L (no) | 1988-11-15 |
| WO1988007526A1 (fr) | 1988-10-06 |
| DE3851769T2 (de) | 1995-03-09 |
| AU619744B2 (en) | 1992-02-06 |
| PT87068B (pt) | 1992-07-31 |
| AU1596488A (en) | 1988-11-02 |
| DK165688B (da) | 1993-01-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK165688C (da) | 5,7,8-trisubstituerede 2,3,4,5-tetrahydro-1h-3-benzazepiner, farmaceutiske praeparater indeholdende forbindelserne og anvendelse af forbindelserne til fremstilling af farmaceutiske praeparater til behandling af psykoser | |
| FI901530A0 (fi) | Menetelmä immunomoduloivien atsaspiraanien valmistamiseksi | |
| PH23607A (en) | Amide derivatives and pharmaceutical composition containing said compounds | |
| DE69332577D1 (de) | Verfahren zur Herstellung von 13-Ether-Derivaten von Milbemycinen und Zwischenprodukte | |
| ATE103812T1 (de) | Zusammensetzung zur behandlung von ischaemischen stoerungen in organen. | |
| DK346788D0 (da) | Thiazolderivater og fremgangsmaade til fremstilling deraf | |
| GB8816773D0 (en) | Insecticidal compounds characterised by enhanced knockdown effect | |
| HUT54277A (en) | Fungicidal compositions comprising 3-(methoxyimino)-propionic acid esters as active ingredient and process for producing the active ingredients | |
| DE69309461D1 (de) | Zusammensetzung zur Beschleunigung der Wundheilung | |
| DK0557192T3 (da) | Pyrethrinoidestere af 6-trifluormethylbenzylalkohol, fremgangsmåde til deres fremstilling og deres anvendelse som pesticider | |
| DE69107561D1 (de) | Verfahren zur Herstellung von 4-Methylsulfonylbenzoesäurederivate und Zwischenprodukte. | |
| HUT43930A (en) | Fungicides comprising naphthimidazolone derivatives as active substance and process for preparing the active substance | |
| GR3026397T3 (en) | Para-hydroxyaniline derivatives, process for their preparation and their use as fungicides or pesticides. | |
| ES2044883T3 (es) | Procedimiento para preparar quinoxalinas sustituidas. | |
| MY103596A (en) | Insecticidal compounds - characterised by enhanced knockdown effect. | |
| ES8400751A1 (es) | "procedimiento para preparar nuevos derivados organofosfonados". | |
| DE69129605D1 (de) | Verfahren zur Herstellung von N-Alkylpyrazolen | |
| DE3361517D1 (en) | Substituted azolylethyl-oximinoalkyl ethers, process for their preparation and their use as fungicides |